Literature DB >> 19587264

Degradation of IRS1 leads to impaired glucose uptake in adipose tissue of the type 2 diabetes mouse model TALLYHO/Jng.

Yun Wang1, Patsy M Nishina, Jürgen K Naggert.   

Abstract

The TALLYHO/Jng (TH) mouse strain is a polygenic model for type 2 diabetes (T2D) characterized by moderate obesity, impaired glucose tolerance and uptake, insulin resistance, and hyperinsulinemia. The goal of this study was to elucidate the molecular mechanisms responsible for the reduced glucose uptake and insulin resistance in the adipose tissue of this model. The translocation and localization of glucose transporter 4 (GLUT4) to the adipocyte plasma membrane were impaired in TH mice compared to control C57BL6/J (B6) mice. These defects were associated with decreased GLUT4 protein, reduced phosphatidylinositol 3-kinase activity, and alterations in the phosphorylation status of insulin receptor substrate 1 (IRS1). Activation of c-Jun N-terminal kinase 1/2, which can phosphorylate IRS1 on Ser307, was significantly higher in TH mice compared with B6 controls. IRS1 protein but not mRNA levels was found to be lower in TH mice than controls. Immunoprecipitation with anti-ubiquitin and western blot analysis of IRS1 protein revealed increased total IRS1 ubiquitination in adipose tissue of TH mice. Suppressor of cytokine signaling 1, known to promote IRS1 ubiquitination and subsequent degradation, was found at significantly higher levels in TH mice compared with B6. Immunohistochemistry showed that IRS1 colocalized with the 20S proteasome in proteasomal structures in TH adipocytes, supporting the notion that IRS1 is actively degraded. Our findings suggest that increased IRS1 degradation and subsequent impaired GLUT4 mobilization play a role in the reduced glucose uptake in insulin resistant TH mice. Since low-IRS1 levels are often observed in human T2D, the TH mouse is an attractive model to investigate mechanisms of insulin resistance and explore new treatments.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19587264      PMCID: PMC2853731          DOI: 10.1677/JOE-09-0026

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  47 in total

1.  Predicting CAP in patients with intermediate PSA using modified PSA indices.

Authors:  A Zisman; D Leibovici; J Kleinmann; Y I Siegel; A Lindner
Journal:  Can J Urol       Date:  2000-12       Impact factor: 1.344

Review 2.  Glucose transporters and insulin action--implications for insulin resistance and diabetes mellitus.

Authors:  P R Shepherd; B B Kahn
Journal:  N Engl J Med       Date:  1999-07-22       Impact factor: 91.245

3.  Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver.

Authors:  E D Abel; O Peroni; J K Kim; Y B Kim; O Boss; E Hadro; T Minnemann; G I Shulman; B B Kahn
Journal:  Nature       Date:  2001-02-08       Impact factor: 49.962

4.  METABOLISM OF ISOLATED FAT CELLS. I. EFFECTS OF HORMONES ON GLUCOSE METABOLISM AND LIPOLYSIS.

Authors:  M RODBELL
Journal:  J Biol Chem       Date:  1964-02       Impact factor: 5.157

5.  Low cellular IRS 1 gene and protein expression predict insulin resistance and NIDDM.

Authors:  E Carvalho; P A Jansson; M Axelsen; J W Eriksson; X Huang; L Groop; C Rondinone; L Sjöström; U Smith
Journal:  FASEB J       Date:  1999-12       Impact factor: 5.191

6.  Genetic factors in type 2 diabetes: the end of the beginning?

Authors:  Stephen O'Rahilly; Inês Barroso; Nicholas J Wareham
Journal:  Science       Date:  2005-01-21       Impact factor: 47.728

Review 7.  Pathogenesis of type 2 diabetes mellitus.

Authors:  Jack L Leahy
Journal:  Arch Med Res       Date:  2005 May-Jun       Impact factor: 2.235

8.  Normal insulin-dependent activation of Akt/protein kinase B, with diminished activation of phosphoinositide 3-kinase, in muscle in type 2 diabetes.

Authors:  Y B Kim; S E Nikoulina; T P Ciaraldi; R R Henry; B B Kahn
Journal:  J Clin Invest       Date:  1999-09       Impact factor: 14.808

Review 9.  Positive and negative regulation of insulin signaling through IRS-1 phosphorylation.

Authors:  Philippe Gual; Yannick Le Marchand-Brustel; Jean-François Tanti
Journal:  Biochimie       Date:  2005-01       Impact factor: 4.079

Review 10.  Animal models of diabetes mellitus.

Authors:  D A Rees; J C Alcolado
Journal:  Diabet Med       Date:  2005-04       Impact factor: 4.359

View more
  20 in total

1.  Erythritol reduces small intestinal glucose absorption, increases muscle glucose uptake, improves glucose metabolic enzymes activities and increases expression of Glut-4 and IRS-1 in type 2 diabetic rats.

Authors:  Chika Ifeanyi Chukwuma; Ramgopal Mopuri; Savania Nagiah; Anil Amichund Chuturgoon; Md Shahidul Islam
Journal:  Eur J Nutr       Date:  2017-08-02       Impact factor: 5.614

Review 2.  Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training.

Authors:  Christian K Roberts; Andrea L Hevener; R James Barnard
Journal:  Compr Physiol       Date:  2013-01       Impact factor: 9.090

3.  Phosphatase specificity and pathway insulation in signaling networks.

Authors:  Michael A Rowland; Brian Harrison; Eric J Deeds
Journal:  Biophys J       Date:  2015-02-17       Impact factor: 4.033

Review 4.  Muscle and adipose tissue insulin resistance: malady without mechanism?

Authors:  Daniel J Fazakerley; James R Krycer; Alison L Kearney; Samantha L Hocking; David E James
Journal:  J Lipid Res       Date:  2018-07-27       Impact factor: 5.922

5.  Metabolic stress-induced activation of FoxO1 triggers diabetic cardiomyopathy in mice.

Authors:  Pavan K Battiprolu; Berdymammet Hojayev; Nan Jiang; Zhao V Wang; Xiang Luo; Myriam Iglewski; John M Shelton; Robert D Gerard; Beverly A Rothermel; Thomas G Gillette; Sergio Lavandero; Joseph A Hill
Journal:  J Clin Invest       Date:  2012-02-13       Impact factor: 14.808

Review 6.  Adipose tissue biology and cardiomyopathy: translational implications.

Authors:  Aslan T Turer; Joseph A Hill; Joel K Elmquist; Philipp E Scherer
Journal:  Circ Res       Date:  2012-12-07       Impact factor: 17.367

7.  Survival Benefit of Exercise Differs by Tumor IRS1 Expression Status in Colorectal Cancer.

Authors:  Akiko Hanyuda; Sun A Kim; Alejandro Martinez-Fernandez; Zhi Rong Qian; Mai Yamauchi; Reiko Nishihara; Teppei Morikawa; Xiaoyun Liao; Kentaro Inamura; Kosuke Mima; Yin Cao; Xuehong Zhang; Kana Wu; Andrew T Chan; Edward L Giovannucci; Jeffrey A Meyerhardt; Charles S Fuchs; Ramesh A Shivdasani; Shuji Ogino
Journal:  Ann Surg Oncol       Date:  2015-11-17       Impact factor: 5.344

8.  AdR1-TG/TALLYHO mice have improved lipid accumulation and insulin sensitivity.

Authors:  Nanlan Luo; Xiangdong Wang; Wei Zhang; W T Garvey; Yuchang Fu
Journal:  Biochem Biophys Res Commun       Date:  2013-03-21       Impact factor: 3.575

Review 9.  Animal models of obesity and diabetes mellitus.

Authors:  Maximilian Kleinert; Christoffer Clemmensen; Susanna M Hofmann; Mary C Moore; Simone Renner; Stephen C Woods; Peter Huypens; Johannes Beckers; Martin Hrabe de Angelis; Annette Schürmann; Mostafa Bakhti; Martin Klingenspor; Mark Heiman; Alan D Cherrington; Michael Ristow; Heiko Lickert; Eckhard Wolf; Peter J Havel; Timo D Müller; Matthias H Tschöp
Journal:  Nat Rev Endocrinol       Date:  2018-01-19       Impact factor: 43.330

10.  Comparison of Two New Mouse Models of Polygenic Type 2 Diabetes at the Jackson Laboratory, NONcNZO10Lt/J and TALLYHO/JngJ.

Authors:  Edward H Leiter; Marjorie Strobel; Adam O'Neill; David Schultz; Andrew Schile; Peter C Reifsnyder
Journal:  J Diabetes Res       Date:  2013-04-08       Impact factor: 4.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.